izpis_h1_title_alt

Cervical intraepithelial neoplasia grade 3 in a HPV-vaccinated patient : a case report
ID Sladič, Mateja (Author), ID Taneska, Pepita (Author), ID Cvjetičanin, Branko (Author), ID Velikonja, Mojca (Author), ID Smrkolj, Vladimir (Author), ID Smrkolj, Špela (Author)

.pdfPDF - Presentation file, Download (16,44 MB)
MD5: 1104256810D8CD244FC108B6C39EE512
URLURL - Source URL, Visit https://www.mdpi.com/1648-9144/58/3/339 This link opens in a new window

Abstract
Persistent infection with human papillomavirus (HPV) causes almost all cervical precancerous lesions and cancers. Bivalent, quadrivalent, and nonavalent HPV vaccines effectively prevent high-grade cervical intraepithelial neoplasia (CIN3). The effectiveness of HPV vaccination against CIN3 is 97–100% in HPV-naïve populations and 44–61% in the overall population. Although HPV vaccination has substantially reduced the incidence of cervical cancers, several cases of precancerous cervical lesions in HPV-vaccinated patients have been reported. We report the clinical case of a 19-year-old woman whose first Pap smear was diagnosed as a high-grade squamous intraepithelial lesion (HSIL) after quadrivalent HPV vaccination. Colposcopy and cervical biopsy were performed, revealing HSIL/CIN3. Our multidisciplinary team decided to take a conservative approach with follow-up visits with cervical biopsies of this young patient. After six months, spontaneous regression of high-grade cervical dysplasia was observed. Although HPV immunization has shown to be extremely effective in preventing a high proportion of cervical precancerous lesions and cervical cancers, HPV vaccines do not protect against all oncogenic high-risk HPV genotypes. Consequently, healthcare providers must encourage HPV-vaccinated women to still regularly attend national cervical screening programs.

Language:English
Keywords:papillomavirus vaccines, Papanicolaou test, cervical intraepithelial neoplasia
Work type:Article
Typology:1.03 - Short Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2022
Number of pages:7 str.
Numbering:Vol. 58, iss. 3, art. 339
PID:20.500.12556/RUL-137257 This link opens in a new window
UDC:618.1
ISSN on article:1648-9144
DOI:10.3390/medicina58030339 This link opens in a new window
COBISS.SI-ID:98924803 This link opens in a new window
Publication date in RUL:08.06.2022
Views:452
Downloads:74
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Medicina
Publisher:MDPI
ISSN:1648-9144
COBISS.SI-ID:6754623 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:01.03.2022

Secondary language

Language:Slovenian
Keywords:cepljenje proti papilomavirusu, maternični vrat, rak materničnega vratu, intraepitelna neoplazija, ginekologija

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back